​We update our analysis of Revenio Group’s subsidiary IcareFinland Oy and revise our estimate of the valuation to 145 MEUR.Icare’s business has developed very favorably and in accordanceto expectations since our last update in 3/2013. The main driverfor elevated value estimate in our report is the potential of thenew HOME product.Icare continues to take market share from old technologiesIcare Finland Oy develops, sells and markets easy to use, portable and painlesstonometers. The products ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.